跳至主要内容
临床试验/CTRI/2014/03/004485
CTRI/2014/03/004485已完成Unknown

A prospective observational study of real world treatment outcomes in patients receiving colistimethate sodium

Cipla Ltd1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年10月14日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
Cipla Ltd
入组人数
100
试验地点
1
主要终点
Clinical Parameters:Clinical and bacteriological

研究概览

简要总结

This clinical trial is a prospective observational study for determination of real world treatment outcomes in subjects with gram negative multidrug resistant bacterial infections receiving colistimethate sodium. 100 patients will be recruited in this study at single site in India. Patients will receive the colistimethate sodium treatment as per the discretion of treating physician.

Primary outcome measures will be Clinical and bacteriological response to the treatment. Safety parameters will be assessed as a secondary measures..

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Greater than 18 years 2.A written informed consent 3.Patients suitable for treatment with colistimethate sodium, including immuno-compromised patients.

排除标准

  • 1.Patients with hypersensitivity to colistimethate sodium or any exipients of its formulation.
  • 2.Patients with Myasthenia gravis.

结局指标

主要结局

Clinical Parameters:Clinical and bacteriological

时间窗: Throughout the study period

response to the treatment.

时间窗: Throughout the study period

次要结局

  • Incidence and nature of adverse events
  • Incidence of inpatient mortality(Throughout the study period)
  • Incidence of drug related adverse events
  • Clinically significant changes in the vital signs, systemic examinations, ECG, chest radiograph and laboratory values(Throughout the study period)

研究者

发起方
Cipla Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验